MORGAN HOOKER: Open Payments
NPI 1801572441 · LIBERTY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 41 payments from 10 companies in 2025. Trend: 2023 $213 · 2024 $653 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $328 |
| Lilly USA, LLC | 12 | $157 |
| Novo Nordisk Inc | 5 | $79 |
| ABBVIE INC. | 3 | $48 |
| PFIZER INC. | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: FARXIGA, MOUNJARO, AIRSUPRA, Ozempic, QULIPTA, JARDIANCE, ELIQUIS, Rybelsus.
Industry payments across SC — which companies pay providers there.
